Clinical Trials Browser

INDUSTRY × dalotuzumab × Other solid neoplasm × Clear all

NCT00635778 2018-10-09

MK-0646-002

Phase 1 Completed

50 enrolled 32 charts

Other solid neoplasm

Advanced Solid Tumors

NCT01431547 2016-06-17

Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)

Phase 1 Completed

Other solid neoplasm

Solid Tumors